GWM
BLCM

Gupta Wealth Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Gupta Wealth Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-300
Closed -$44K – 1380
2015
Q3 		$44K Buy
+300
New +$55.1K 0.01% 476

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Gupta Wealth Management's BLCM Position: Q4 2015 in Review

Gupta Wealth Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2015, closing a stake of 300 shares — an estimated $44K sold.

Gupta Wealth Management first reported a position in BLCM in Q3 2015 and held it in 1 quarter. The position peaked at $44K in Q3 2015. 81 funds tracked by Wall St. Rank hold BLCM as of Q4 2015.

  • Gupta Wealth Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Gupta Wealth Management sold 300 Bellicum Pharmaceuticals, Inc. shares in Q4 2015, an estimated $44K.
  • Gupta Wealth Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Gupta Wealth Management's Bellicum Pharmaceuticals, Inc. position peaked at $44K in Q3 2015.
  • 81 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2015.

Based on Gupta Wealth Management's 13F filing for Q4 2015, filed 17 Feb 2016.